Solvents: Clinical Trials

2 trials of Solvents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Solvents: new trials by email Literature Review of Solvents trials Research Report on Solvents

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19
EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19), Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%) - Covid19
Phase 1 / Phase 2CompletedFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"1002020-07-272022-03-16
Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. - Cystic Fibrosis
Phase 1CompletedNeupharma Srl122019-10-252020-12-09

Conditions studied

COVID-19 (1)  ·  Cystic Fibrosis (1)

Sponsors

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (1)  ·  Neupharma Srl (1)

Countries

Italy (1)  ·  Russia (1)

Top investigators

Giulia Paiola, MD (1)  ·  Vladimir I. Kuzubov (1)